CGEM
Cullinan Therapeutics, Inc. · Healthcare
Director and 10% owner Ansbert Gadicke sold $774K of Cullinan Therapeutics, Inc.
Sold$773,720
$29.23Price
26,468Shares
What CGEM did after the filing
- The stock from Tue, Sep 14 open, $28.85
- −24.6%
- S&P 500, same days
- +2.1%
Measured over 30 trading days, to the Oct 26 close.
Traded Thu, Sep 9. Filed Mon, Sep 13. Returns use the Sep 14 open and the Oct 26 close. Not investment advice.